IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350 | -12.3% | 76,850 | +35.8% | 0.03% | -15.6% |
| Q2 2023 | $399 | +5.0% | 56,609 | -9.0% | 0.03% | +14.3% |
| Q1 2023 | $380 | -2.3% | 62,188 | +2.0% | 0.03% | -12.5% |
| Q4 2022 | $389 | -99.9% | 60,952 | +43.3% | 0.03% | -15.8% |
| Q3 2022 | $407,000 | -30.1% | 42,531 | -19.4% | 0.04% | -28.3% |
| Q2 2022 | $582,000 | +71.7% | 52,755 | +159.2% | 0.05% | +381.8% |
| Q1 2022 | $339,000 | – | 20,353 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |